Lipids and Stroke
Arch Neurol 53:303-308, Hachinski,V.,et al, 1996
Risk Factors for Cervical Atherosclerosis in patients with Transient Ischemic Attack or Minor Ischemic Stroke
Stroke 24:970-975, Palomaki,H.,et al, 1993
Platelet Coagulant Activities & Serum Lipids In Transient Cerebral Ischemia
NEJM 295:854, Walsh,P.N.,et al, 1976
Case Record of MGH-NEJM Atheromatous Emboli to Brain
Kidney, 286:11461972., , 1972
A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke
NEJM 382:9-19,81, Amarenco, P.,et al, 2020
Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
Aggressive Medical Therapy Alone is Not Adequate in Certain Patients with Severe Symptomatic Carotid Stenosis
Stroke 44:2955-2956, Brown, M.M., 2013
Aggressive Medical Therapy Alone is Adequate in Certain Patients with Severe Symptomatic Carotid Stenosis
Stroke 44:2957-2958, Chaturvedi, S.,et al, 2013
Reduction in Early Stroke Risk in Carotid Stenosis with Transient Ischemic Attack Associated with Statin Treatment
Stroke 44:2814-2820, Merwick, A.,et al, 2013
Sporadic Cerebral Amyloid Angiopathy Revisited: Recent Insights Into Pathophysiology and Clinical Spectrum
JNNP 83:124-137, Charidimou,A.,et al, 2012
Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack
NEJM 366:1914-1922;, Davis, S.M. & Donnan, G.A., 2012
Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010
Watershed Infarcts in Transient Ischemic Attack/Minor Stroke With =50% Carotid Stenosis: Hemodynamic or Embolic?
Stroke 41:1410-1416, Moustafa,R.R., et al, 2010
A Guide to Imaging for Common Neurological Problems
BMJ 341:388-393, Cohen,A.B., et al, 2010
Pathophysiology of Thrombotic Thrombocytopenic Purpura
Int J Hematol 91:1-30, Tsai, H.M., 2010
Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes
Stroke 40:1405-1409, Amarenco,P.,et al, 2009
Relative Effects of Statin Therapy on Stroke and Cardiovascular Events in Men and Women: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study
Stroke 39:2444-2448, Goldstein,L.B.,et al., 2008
Transient Bilateral Cortical Visual Loss After Coronary Artery Bypass Grafting in a Normotensive Risk-Free Patient
Heart Surg Forum 11:#2008-1014, Bagheri, J.,et al, 2008
High-Dose Atorvastatin After Stroke or Transient Ischemic Attack
NEJM 355:549-559,613, The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators, 2006
Expanding Indications for Statins in Cerebral Ischemia
Arch Neurol 62:67-72,23, Ovbiagele,B.,et al, 2005
Neurological presentation of intravascular lymphoma: report of two cases and discussion of diagnostic challenges
Eur J Neurol 12:710-714, Lozsadi, D.A.,et al, 2005
Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 34:105-110, Lalouschek,W.,et al, 2003
Should I Start All My Ischaemic Stroke and TIA Patients on a Statin, an ACE Inhibitor, a Diuretic, and Aspirin Today?
JNNP 74:1461-1464, Sandercock,P.A.G., 2003
Prognostic Importance of Leukoaraiosis in Patients with Symptomatic Internal Carotid Artery Stenosis
Stroke 33:1651-1655, Streifler,J.Y.,et al, 2002
Suppression of Recurrent Transient Ischemic Attacks by a Statin Agent
Neurol 56:531-532, Alberts,M.J., 2001
Cerebral Hemispheric Low-Flow Infarcts in Arterial Occlusive Disease:Lesion Patterns and Angiomorphological Conditions
Stroke 28:118-123, Mull,M.,et al, 1997
Cerebrovascular complic of Neurocysticercosis, Clin & Neuroimaging Spectrum
Arch Neurol 53:233-239, Cantu,C.&Barinagarrementeria,F., 1996
Ischemic Stroke as First Manifestation of Essential Thrombocythemia, Report of Six Cases
Stroke 26:1463-1466, Arboix,A.,et al, 1995
Recurrent Stroke and Thrombo-Occlusive Events in the Antiphospholipid Syndrome
Ann Neurol 38:119-124, Levine,S.R.,et al, 1995
Transient Neurologic and Ocular Manifestations in Primary Thrombocythemia
Neurol 43:1107-1110, Michiels,J.J.,et al, 1993
Fibrinogen and Lipid Concentrations as Risk Factors for Transient Ischemic Attacks & Minor Ischaemic Strokes
BMJ 303:605-609, Qizilbash,N.,et al, 1991
Cerebrovascular and Neurologic Disease Associated with Antiphospholipid Antibodies:48 Cases
Neurol 40:1181-1189, Levine,S.R.,et al, 1990
Orthostatic Hypotension as a Risk Factor for Symptomatic Occlusive Cerebrovascular Disease
Neurol 39:30-34, Dobkin,B.H., 1989
Cerebrovascular Ischemia Associated with Lupus Anticoagulant
Stroke 18:257-263, Levine,S.R.&Welch,K.M.A., 1987
Hyperlipidemia is a Risk Factor for Decreased Cerebral Perfusion & Stroke
Arch Neurol 44:418-422, Meyer,J.S.,et al, 1987
Cerebral Infarct, TIA, & Lupus Inhibitor
Neurol 36:1234-1237, Fisher,M.&McGehee,W., 1986
Neurologic Manifestations of Essential Thrombocythemia
Ann Int Med 99:513-518, Jabaily,J.,et al, 1983
Cholesterol Embolism as a Cause of Transient Ischemic Attacks & Cerebral Infarction
Neurol 31:860-865, Beal,M.F.,et al, 1981
Cardiac Myxoma:A Diagnostic Challenge for the Neurologist
Neurol 26:1060, Yufe,R.,et al, 1976
Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease
NEJM 293:174, Genton,E.,et al, 1975
Neurologic Manifest. of Infective Endocarditis:A Review
Stroke 4:958, Greenlee,J.E.,et al, 1973
Case Record of MGH-NEJM Subdural Hematoma Secondary to Metastasis & Lacunar Infarcts
286:650, , 1972
Lesions in Cerebrovascular Disease & their Clinical Implications
BMJ 89, Hutchinson,E.C., 1972
Examination of the Brain & Spinal Cord
Neuropathology, Little, Brown & Co. (Tedeschi) 1970., Romanul,F., 1970
Idiopathic Thrombocytosis
Neurol 18:711-713, Levine,J.,et al, 1968